Oscar Silva

Clinical Assistant Professor, Pathology

Bio

Oscar is an academic hematopathologist who completed anatomic and clinical pathology residency and hematopathology fellowship at Stanford in 2020. Prior to Stanford, he received his MD and PhD from UCLA. His interests include immunology, the pathogenesis and diagnosis of lymphomas, and global health.

Clinical Focus

Hematopathology
Anatomical and Clinical Pathology
Anatomic and Clinical Pathology

Academic Appointments

Clinical Assistant Professor, Pathology
Member, Maternal & Child Health Research Institute (MCHRI)

Professional Education

Board Certification: American Board of Pathology, Anatomic and Clinical Pathology (2020)
Board Certification: American Board of Pathology, Hematopathology (2021)
Fellowship: Stanford University Hemapathology Fellowship (2018) CA
Residency: Stanford University Pathology Residency (2020) CA
Medical Education: UCLA David Geffen School Of Medicine Registrar (2015) CA
M.D., University of California, Los Angeles (2015)
Ph.D, University of California, Los Angeles, Immunology (2013)

Contact

Academic osilva@stanford.edu Tel: (650) 723-7211Tel: (650) 497-1553 Fax: (650) 725-6902

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Department of Pathology 300 Pasteur Dr Rm B211 B211 MC 5324 Stanford CA 94305 Tel: (650) 723-3685 Fax: (650) 725-4709

Additional Clinical Info

All Publications

Profiles With Related Publications

close
Sean Bendall

Associate Professor of Pathology
Research Interests
Our goal is to understand the mechanisms regulating the development of human systems. Drawing on both pluripotent stem cell biology, hematopoiesis, and immunology, combined with novel high-content single-cell analysis (CyTOF – Mass Cytometry) and imagining (MIBI-Multiplexed Ion Beam Imaging) we are creating templates of ‘normal’ human cellular behavior to both discover novel regulatory events and cell populations as well as understand dysfunctional processes such as cancer.

163 Total Publications
close
Helen M. Blau

Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Research Interests
Prof. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.

299 Total Publications
close
Francesca Briganti

Instructor, Cardiovascular Institute

9 Total Publications
close
Yueh-hsiu Chien

Professor of Microbiology & Immunology
Research Interests
Contribution of T cells to immunocompetence and autoimmunity; how the immune system clears infection, avoids autoimmunity and how infection impacts on the development of immune responses.

107 Total Publications
close
Le Cong

Assistant Professor of Pathology (Pathology Research) and of Genetics
Research Interests
Our lab are developing gene-editing technologies, such as CRISPR systems for in vivo therapy, and cleavage-free techniques for large gene insertion via microbial recombinase. Our team also pioneers in single-cell tracking for cancer and immunology studies using novel CRISPR tools. To accelerate our work, we integrate AI and machine learning into these technologies, design and evolve proteins/RNAs, pushing frontiers in understanding and treating neurological and immunological disease.

39 Total Publications
close
Gerald Crabtree

David Korn, MD, Professor of Pathology and Professor of Developmental Biology
Research Interests
Chromatin regulation and its roles in human cancer and the development of the nervous system. Engineering new methods for studying and controlling chromatin and epigenetic regulation in living cells.

262 Total Publications
close
Edgar Engleman

Professor of Pathology and of Medicine (Immunology and Rheumatology)
Research Interests
Dendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.

286 Total Publications
close
C. Garrison Fathman

Professor of Medicine (Immunology and Rheumatology), Emeritus
Research Interests
My lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.

326 Total Publications
close
Jorg Goronzy

Professor of Medicine (Immunology and Rheumatology), Emeritus

482 Total Publications
close
Joseph Hernandez

Clinical Assistant Professor, Pediatrics - Immunology and Allergy
Clinical Focus
Allergy and Immunology, Food allergy, allergic rhinitis, asthma, immune deficiency

33 Total Publications
close
Wilson F Kuswanto, MD, PhD

Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology
Clinical Focus
Tissue inflammation, Rheumatology, Osteoarthritis, Rheumatoid Arthritis, Sjögren's syndrome, Sarcoidosis, Internal Medicine

12 Total Publications
close
David B. Lewis

Naddisy Foundation Professor of Pediatric Food Allergy, Immunology, and Asthma
Clinical Focus
Primary Immunodeficiency, Pediatrics
Research Interests
My laboratory is focused on defining cellular and molecular mechanisms that limit T cell responses to vaccines and pathogens during normal early postnatal development and in cases of inherited genetic immunodeficiencies. We are also determinomg how these limitations in immunity can be overcome by using novel approaches for vaccine adjuvants for influenza vaccine and by using catalytically inactive Cas proteins for inducing endogenous gene expression.

176 Total Publications